Weight Loss Diet Solutions – Page 473 – Weight Loss Diet Solutions

Weight Loss Dietary Supplements Market Touches New High at US$ 37177.6 Million by 2026

Post author By admin
Post date July 31, 2018
No Comments on Weight Loss Dietary Supplements Market Touches New High at US$ 37177.6 Million by 2026

As per the latest study by Persistence Market Research (PMR), the global weight loss dietary supplements market is anticipated to witness healthy growth. The market is likely to register 6.0% CAGR throughout the forecast period 2017-2026. The global weight loss dietary supplements market is also estimated to bring in US$ 37,177.6 million revenue by 2026 end.

With obesity becoming a global health concern, weight loss continues to be one of the most focused areas. Hence, increasing number of companies are coming up with the new products in weight loss supplements. The increasing consumption and demand for weight loss dietary supplements, regulations on the production of these supplements along with ingredients used are also gaining traction in various countries. The government in various countries are also focusing on the quality and quantity of ingredients used and if any of these ingredients can have severe side-effects, affecting the health of the consumers negatively.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/20380

Increasing use of Natural and Organic Ingredients in the Weight Loss Dietary Supplements

The negative effects of being obese and overweight are resulting in the increasing use of weight management products. Consumers are also adopting weight loss supplements in forms of pill, liquid, and powder. Hence, with the increase in the use of these supplements, manufacturers are also trying to produce safer products, thereby using organic and natural ingredients and plant-based ingredients. Among various ingredients, green tea extract is considered as one of the most popular and safest ingredients in the weight loss dietary supplements. Similarly, Garcinia cambogia is also being considered as an ingredient in the weight loss supplements. However, these ingredients have been reported to have adverse effects like a headache, constipation, UTI. Hence, there has been an increase in the investment in the research on other organic ingredients that can be used to produce weight loss supplements.

Global Weight Loss Dietary Supplements Market: Segmental Insights

The global weight loss dietary supplements market includes various segments such as end-user, form, ingredients, distribution channel, and region. Based on the form, the market is categorized into powder, liquid, and soft gell/pills. Soft gell/pills are expected to dominate the market during the forecast period. By the end of 2026, soft gell/pills are expected to exceed US$ 18,500 million revenue.

Based on the end-user, the segment consists of men, women and senior citizen. Among these, women are expected to be the largest users of weight loss dietary supplements. Women segment as the end-user is estimated to create an incremental opportunity of more than US$ 7,900 million between 2017 and 2026.

By Distribution Channel, pharmacies drug store is expected to emerge as the largest distribution channel for the weight loss dietary supplements. Pharmacies drug store is estimated to account for more than one-third of the revenue share by the end of 2017.

Based on the ingredients, the segment consists of amino acids, vitamins minerals, botanical supplements, and others. Vitamins minerals are expected to emerge as one of the largest used ingredients in the weight loss dietary supplements. By the end of 2026, vitamins minerals are estimated to exceed US$ 16,900 million revenue.

Region-wise, the market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among the given regions, North America is expected to dominate the global weight loss dietary supplements market throughout the forecast period 2017-2026.

Access Report with Table of Contents @ https://www.persistencemarketresearch.com/methodology/20380

Global Weight Loss Dietary Supplements Market: Competitive Assessment

Key players in the global weight loss dietary supplements market are Amway (Nutrilite), Abott Laboratories, GlaxoSmithKline, Glanbia, Herbalife International, Pfizer, American Health, Stepan, Nature’s Sunshine Products, and FANCL.

Tags Garcinia cambogia

Weight Loss Products

Relevium’s Bioganix® Gold Series Nutraceuticals Live on Walmart.com

Post author By admin
Post date July 31, 2018
No Comments on Relevium’s Bioganix® Gold Series Nutraceuticals Live on Walmart.com

MONTREAL, July 30, 2018 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are currently live and available for purchase.

Relevium received today the final product listing approvals by the quality control team at Walmart.com and has begun selling its Bioganix® Gold Series nutraceutical products. As initially announced on May 3, 2018 the Company had received brand approval from Walmart.com to sell in its marketplace and today the Company received final approval for its initial product listing, which are currently live and available for purchase in the United States.

Bioganix® Gold Series is a unique and exclusive line of nutraceutical supplements designed exclusively for discerning health and wellness Walmart.com shoppers. The Company has launched an initial four (4) SKUs comprised of exclusive formulations from some of the highest volume sellers in the Bioganix® product line. The company’s Bioganix Gold Series products includes; Apple Cider Vinegar Capsules, BioPro Advanced Probiotic, Garcinia Cambogia and Pure Forskolin.

Aurelio Useche, CEO of Relevium stated: “The BioGanix® Gold Series is an exclusive Walmart.com line of nutraceuticals and supplements that gives the Company access to a new consumer base” Mr. Useche continued: “Our expectations for the new brand and the Walmart.com channel are high and we believe we will be able to scale the business and expand our available SKUs considerably faster than through our traditional distribution channels”

Abis Hussain, CMO of Relevium, stated: “In the coming months we will establish a working relationship with Walmart as we market our initial batch of products. Depending on demand, available traffic, conversion rates and ultimately profit margins, we will quickly move to launching additional exclusive products to Walmart.com through our Bioganix® Gold Series Nutraceutical brand”

Shareholders should expect updates on the initial performance Walmart.com in Q2 of this fiscal year.

About Relevium Technologies

Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or brands with a focus on e-commerce in the growing health and wellness sector. The Company, through its wholly-owned subsidiary, Biocannabix Health Corporation, is also incorporating cannabinoids into its nutraceutical strategy and provide its retail customers access to the health benefits of cannabis through its formulations and established brands.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

On Behalf of the Board of Directors

RELEVIUM TECHNOLOGIES INC.

Aurelio Useche
President and CEO

For more information about this press release:

Tel: +1.888.528.8687

RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn

Tags Garcinia cambogia

Weight Loss Exercise

Can You Be Fat and Fit?

Often we see people that run or workout, and are kind of overweight, or we ourselves can be overweight but exercise, and think that being fat and fit is good enough. Really the fitness level seems important and your weight isn’t that important. Right?

Well that isn’t really true. You have to lower your fat level as well as get fit to be more healthy

The study results are in. If you want to reduce the risk of dying before your time, being fat and fit isn’t the way to go. Ditto for being slender but not fit. Fat and sedentary is the worst combination, of course. Lean and fit is the best way to live out your years.

Sounds logical, especially in view of all the recent hand-wringing about rising obesity rates. Nevertheless, whether exercise can overcome the risk of being over has been controversial, until now.

Early in 1999, Steven Blair, director of research at the Cooper Institute of Aerobics in Dallas, opined that you can be fat and fit and that would be good enough. In the men who are over or obese, but also moderately or high-fit, we don’t see much increase in the risk of dying, he told Nutrition Action Health Letter.

Can You Be Fat and Fit?

There has been some suggestion that if you are particularly active, you don’t have to worry about your fat, or about your diet, Dr. Frank Hu, lead author of the new study from the Harvard School of Public Health, told the Associated Press. That’s very misleading.

A Harvard study that was large and impressive, encompassing approximately 2.7 million person-years. The researchers followed 116,564 female registered nurses for 24 years. The nurses were 30 to 55 and healthy when the study began in 1976.

The nurses, all non-smokers, were monitored for physical activity and body mass. During the course of the study, 10, 282 died: 2370 from cardiovascular disease, 5223 from cancer, and 2689 from other causes.

The researchers found that being over or obese increased the risk of death regardless of the level of physical activity. Exercise helped, but did not overcome the higher risk of death associated with being fat.

Slender but inactive women were 55% more likely to die. Those who were both sedentary and obese were almost two and one-half times more likely to die.

Women who were both lean and physically active had the lowest mortality, the researchers reported.
Being physically active did not cancel out the increased mortality of over, Dr. Hu stated.

Applauding the Harvard study, Dr. Timothy Church of the Cooper Institute of Aerobics Research told the AP: If you’re lean but you’re sedentary, don’t fool yourself. You’re still at risk. You need to get physically active.

Thin and Fit Is The Way To Live

Another study done by researchers at Imperial college and University College in London. That Study had over 17,000 subjects and found the same thing

Waist circumference was similarly associated with heart disease risk (HR 1.32, 95% CI 1.24 to 1.41). Again, adjusting for blood pressure, cholesterol and diabetes similarly reduced the link so it was on the threshold of significance.

Metabolically healthy obese people had a 28% increased risk of heart disease compared with metabolically healthy normal weight people

Clearly, the best way to live to a ripe old age is to watch what you eat and exercise. According to that research there is no way that you can be fat and fit at the same time.

There has been some suggestion that if you are particularly active, you dont have to worry about your body, about your diet, Dr. Frank Hu, lead author of the new study from the Harvard School of Public Health, told the Associated Press. Thats very misleading.

The Harvard study was large and impressive, encompassing approximately 2.7 million person-years. The researchers followed 116,564 female registered nurses for 24 years. The nurses were 30 to 55 and healthy when the study began in 1976. The nurses, all non-smokers, were monitored for physical activity and body mass. During the course of the study, 10, 282 died: 2370 from cardiovascular disease, 5223 from cancer, and 2689 from other causes.

Obese women who did brisk walking or other more rigorous activity three-and-one-half hours or more per week were, nevertheless, almost twice as likely (91 %) to die as those who were both active and lean. Slender but inactive women were 55% more likely to die. Those who were both sedentary and obese were almost two and one-half times more likely to die.

Women who were both lean and physically active had the lowest mortality, the researchers reported.

Being physically active did not cancel out the increased mortality of over, Dr. Hu stated.

Applauding the Harvard study, Dr. Timothy Church of the Cooper Institute of Aerobics Research told the AP: If youre lean but youre sedentary, dont fool yourself. Youre still at risk. You need to get physically active.

Clearly, the best way to live to a ripe old age is to watch what you eat and exercise.

Tags Fitness